Congenital systemic veins anomaly

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3091
Who is this for?
Show terms as
3Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Congenital systemic veins anomaly (also referred to as congenital anomalies of the systemic venous return) encompasses a group of rare developmental malformations affecting the major veins that return deoxygenated blood to the heart. These anomalies arise during embryonic development when the normal remodeling of the cardinal venous system fails to occur properly. The most commonly recognized forms include persistent left superior vena cava (PLSVC), absence or atresia of the right superior vena cava, anomalous drainage of the inferior vena cava (such as interrupted inferior vena cava with azygos or hemiazygos continuation), and duplication of the inferior vena cava. These conditions primarily affect the cardiovascular system. Many individuals with isolated systemic venous anomalies are asymptomatic, and the condition may be discovered incidentally during imaging studies or during placement of central venous catheters. However, in some cases, these anomalies can be associated with other congenital heart defects, including atrial septal defects, atrioventricular canal defects, or heterotaxy syndromes (abnormalities of left-right body asymmetry). When symptomatic, patients may experience arrhythmias, cyanosis (if there is right-to-left shunting), or complications related to associated cardiac malformations. In the context of heterotaxy, systemic venous anomalies may be part of a more complex clinical picture involving splenic abnormalities and visceral organ malposition. Treatment depends on the specific anomaly and its clinical significance. Isolated anomalies that are hemodynamically insignificant typically require no intervention but are important to document for future surgical or interventional planning. When associated with significant congenital heart disease, surgical correction may be necessary. Awareness of these anomalies is critical during cardiac surgery, pacemaker implantation, and central line placement to avoid complications. Long-term follow-up with a cardiologist is recommended for patients with complex forms or associated cardiac defects.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Congenital systemic veins anomaly.

View clinical trials →

No actively recruiting trials found for Congenital systemic veins anomaly at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Congenital systemic veins anomaly community →

Specialists

3 foundView all specialists →
SM
SALLY E MITCHELL, MD
Specialist
PI on 1 active trial
DM
Denis HERBRETEAU, MD
Specialist
PI on 1 active trial
PM
PATRICK DUPUY, MD
BEDFORD, MA
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Congenital systemic veins anomaly.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Congenital systemic veins anomalyForum →

No community posts yet. Be the first to share your experience with Congenital systemic veins anomaly.

Start the conversation →

Latest news about Congenital systemic veins anomaly

No recent news articles for Congenital systemic veins anomaly.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Congenital systemic veins anomaly

What is Congenital systemic veins anomaly?

Congenital systemic veins anomaly (also referred to as congenital anomalies of the systemic venous return) encompasses a group of rare developmental malformations affecting the major veins that return deoxygenated blood to the heart. These anomalies arise during embryonic development when the normal remodeling of the cardinal venous system fails to occur properly. The most commonly recognized forms include persistent left superior vena cava (PLSVC), absence or atresia of the right superior vena cava, anomalous drainage of the inferior vena cava (such as interrupted inferior vena cava with azyg

At what age does Congenital systemic veins anomaly typically begin?

Typical onset of Congenital systemic veins anomaly is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Congenital systemic veins anomaly?

3 specialists and care centers treating Congenital systemic veins anomaly are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.